4/25
01:00 am
ipsc
Low
Report
4/24
07:27 am
ipsc
Century Therapeutics: A Biotech With Interesting Optionality Opportunities [Seeking Alpha]
Low
Report
Century Therapeutics: A Biotech With Interesting Optionality Opportunities [Seeking Alpha]
4/21
07:04 am
ipsc
Century Therapeutics (IPSC) had its "buy" rating reaffirmed by HC Wainwright.
Low
Report
Century Therapeutics (IPSC) had its "buy" rating reaffirmed by HC Wainwright.
4/8
06:04 am
ipsc
Century Therapeutics (IPSC) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
Neutral
Report
Century Therapeutics (IPSC) had its "sell (d-)" rating reaffirmed by
Weiss Ratings.
3/14
06:58 am
ipsc
Century Therapeutics (IPSC) was downgraded by Zacks Research from "strong-buy" to "hold".
Medium
Report
Century Therapeutics (IPSC) was downgraded by Zacks Research from "strong-buy" to "hold".
3/12
08:38 am
ipsc
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]
High
Report
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates [Yahoo! Finance]
3/12
08:00 am
ipsc
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
High
Report
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
3/7
02:59 am
ipsc
High
Report
2/25
08:14 am
ipsc
Century Therapeutics to Participate in Upcoming Investor Conferences in March [Yahoo! Finance]
Low
Report
Century Therapeutics to Participate in Upcoming Investor Conferences in March [Yahoo! Finance]
2/25
08:00 am
ipsc
Century Therapeutics (IPSC) is now covered by TD Cowen. They set a "buy" rating on the stock.
Medium
Report
Century Therapeutics (IPSC) is now covered by TD Cowen. They set a "buy" rating on the stock.
2/25
08:00 am
ipsc
Century Therapeutics to Participate in Upcoming Investor Conferences in March
Medium
Report
Century Therapeutics to Participate in Upcoming Investor Conferences in March
2/9
11:21 am
ipsc
Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race [Seeking Alpha]
Medium
Report
Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race [Seeking Alpha]
2/1
01:30 am
ipsc
Century Therapeutics (NASDAQ:IPSC) was downgraded by analysts at
Wall St
Medium
Report
Century Therapeutics (NASDAQ:IPSC) was downgraded by analysts at
Wall St
1/30
03:28 pm
ipsc
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission [Yahoo! Finance]
Low
Report
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission [Yahoo! Finance]